1. Primary prevention of ovarian cancer by salpingectomy: that's one small step for a surgeon, one giant leap for patients

   • Ingo B. Runnebaum
   • Angela Kather

   Guest Editorial Open access 29 March 2023 Pages: 6799 - 6801

   

2. Discovery of potential biomarkers for lung cancer classification based on human proteome microarrays using Stochastic Gradient Boosting approach

   • Ning Yao
   • Jianbo Pan
   • Yazhou Wu

   Research 18 February 2023 Pages: 6803 - 6812

   

3. A survival prediction model via interpretable machine learning for patients with oropharyngeal cancer following radiotherapy

   • Xiaoying Pan
   • Tianhao Feng
   • X. Sharon Qi

   Research 18 February 2023 Pages: 6813 - 6825

   

4. GNRH family genes contributed to gender-specific disparity of bladder cancer prognosis through exerting opposite regulatory roles between males and females

   • Yuxuan Song
   • Caipeng Qin
   • Tao Xu

   Research 19 February 2023 Pages: 6827 - 6840

   

5. Bleeding-related re-exploration following pulmonary resection: a report of a single-center experience

   • Shanbo Zheng
   • Ting Ye
   • Haiquan Chen

   Research 20 February 2023 Pages: 6841 - 6848

   

6. The prognostic role of HIF-1α and NF-κB expression in RAS wild-type metastatic colorectal cancer: A Turkish Oncology Group (TOG) study

   • Aykut Demirkıran
   • Fahriye Kılınç
   • Mehmet Artaç

   Research 20 February 2023 Pages: 6849 - 6856

   

7. Risk mapping of lung cancer: a comprehensive appraisal of published meta-analyses incorporating Mendelian randomization studies

   • Caichen Li
   • Jianfu Li
   • Wenhua Liang

   Research 21 February 2023 Pages: 6857 - 6873

   

8. ePRO symptom follow-up of colorectal cancer patients receiving oxaliplatin-based adjuvant chemotherapy is feasible and enhances the quality of patient care: a prospective multicenter study

   • Sanna Iivanainen
   • Ravi Ravichandra
   • Jussi P. Koivunen

   Research Open access 21 February 2023 Pages: 6875 - 6882

   

9. Inhibition of Polo-like kinase 1 (PLK1) triggers cell apoptosis via ROS-caused mitochondrial dysfunction in colorectal carcinoma

   • Ya Feng
   • Tianjiao Li
   • Chenggang Li

   Research 22 February 2023 Pages: 6883 - 6899

   

10. Molecular phenotypic linkage between N⁶-methyladenosine methylation and tumor immune microenvironment in hepatocellular carcinoma

    • Feng Zhang
    • Junming Bi
    • Shuijiao Guo

    Research 24 February 2023 Pages: 6901 - 6916

    

11. Dissecting the inflammatory tumor microenvironment of esophageal adenocarcinoma: mast cells and natural killer cells are favorable prognostic factors and associated with less extensive disease

    • Alyne Condurú dos Santos Cunha
    • Adrian Georg Simon
    • Alexander Quaas

    Research Open access 24 February 2023 Pages: 6917 - 6929

    

12. Selinexor demonstrates anti-tumor efficacy in paired patient-derived xenograft models and hydrogel-embedded histoculture drug sensitivity test of penile cancer

    • Yuanqiao He
    • Jiaqi Mei
    • Xiongbing Lu

    Research 25 February 2023 Pages: 6931 - 6941

    

13. Extracapsular extension of transitional zone prostate cancer miss-detected by multiparametric magnetic resonance imaging

    • Xin Chen
    • Wei Li
    • Xuedong Wei

    Research 27 February 2023 Pages: 6943 - 6952

    

14. Ovarian cancer prevention by opportunistic salpingectomy is a new de facto standard in Germany

    • I. B. Runnebaum
    • A. Kather
    • J. Sehouli

    Research Open access 27 February 2023 Pages: 6953 - 6966

    

15. Integrative analyses of bulk microarray data to discover genes, pathways, and immune infiltration characteristics associated with targeting of Ewing sarcoma

    • Binjie Cao
    • Haijian Sun
    • Haibo Sun

    Research Open access 27 February 2023 Pages: 6967 - 6977

    

16. Sequential treatment of metastatic renal cell carcinoma patients after first-line vascular endothelial growth factor targeted therapy in a real-world setting: epidemiologic, noninterventional, retrospective–prospective cohort multicentre study

    • Alvydas Cesas
    • Vincas Urbonas
    • Ignas Gaidamavicius

    Research Open access 27 February 2023 Pages: 6979 - 6988

    

17. Individual hematotoxicity prediction of further chemotherapy cycles by dynamic mathematical models in patients with gastrointestinal tumors

    • Vivien Topf
    • Yuri Kheifetz
    • Maren Knödler

    Research Open access 28 February 2023 Pages: 6989 - 6998

    

18. The relationship of airflow limitation with lung squamous cell carcinoma: evidence from mendelian randomization analysis

    • Qing Zhang
    • Guannan Cai
    • Ying Chen

    Research 28 February 2023 Pages: 6999 - 7006

19. Whole body irradiation with intensity-modulated helical tomotherapy prior to haematopoietic stem cell transplantation: analysis of organs at risk by dose and its effect on blood kinetics

    • Mümtaz Köksal
    • Jonathan Baumert
    • Leonard C. Schmeel

    Research Open access 01 March 2023 Pages: 7007 - 7015

    

20. Based on ARASENS trial: efficacy and safety of darolutamide as an emerging option of endocrinotherapy for metastatic hormone-sensitive prostate cancer—an updated systematic review and network meta-analysis

    • Maoyang Dou
    • Hao Liang
    • Benkang Shi

    Research 01 March 2023 Pages: 7017 - 7027

    

21. The investigation of volatile organic compounds in diagnosing (early) esophageal squamous cell carcinoma and gastric adenocarcinoma

    • Hang Yang
    • Chengfang Xiang
    • Bing Hu

    Research 02 March 2023 Pages: 7029 - 7041

    

22. Adverse outcomes and health-ecological influencing factors of preoperative frailty among elderly patients with gastric cancer

    • Lingyu Ding
    • Xueyi Miao
    • Qin Xu

    Research 02 March 2023 Pages: 7043 - 7051

23. Palmitic acid combined with γ-interferon inhibits gastric cancer progression by modulating tumor-associated macrophages’ polarization via the TLR4 pathway

    • Yan-Yan Zhang
    • Jian Li
    • Li Feng

    Research 02 March 2023 Pages: 7053 - 7067

    

24. Heterodimerization of cholecystokinin 1 and cholecystokinin 2 receptors in gallbladder cancer: a new mechanism for carcinogenesis

    • Jaya Nigam
    • Hasan Raza Kazmi
    • Abhijit Chandra

    Research 04 March 2023 Pages: 7069 - 7078

    

25. Testicular neoplasms: the interrelationships of serum levels of microRNA-371a-3p (M371) and classical tumor markers with histology, clinical staging, and age—a statistical analysis

    • Klaus-Peter Dieckmann
    • Cansu Dumlupinar
    • Gazanfer Belge

    Research Open access 04 March 2023 Pages: 7079 - 7090

    

26. Survival outcomes of patients newly diagnosed with diffuse large B-cell lymphoma: real-world evidence from a German claims database

    • Peter Borchmann
    • Jan-Michel Heger
    • Barbara Werner

    Research 05 March 2023 Pages: 7091 - 7101

    

27. The interplay between telomeric complex members and BCR::ABL1 oncogenic tyrosine kinase in the maintenance of telomere length in chronic myeloid leukemia

    • Anna Deręgowska
    • Monika Pępek
    • Tomasz Stokłosa

    Research Open access 05 March 2023 Pages: 7103 - 7112

    

28. TOP-PIC: a new tool to optimize pharmacotherapy and reduce polypharmacy in patients with incurable cancer

    • Irene Strassl
    • Armin Windhager
    • Ansgar Weltermann

    Research Open access 06 March 2023 Pages: 7113 - 7123

    

29. The significance of spread through air spaces in the prognostic assessment model of stage I lung adenocarcinoma and the exploration of its invasion mechanism

    • YangYang Niu
    • XinHao Han
    • XiaoMei Li

    Research 07 March 2023 Pages: 7125 - 7138

    

30. PLVAP protein expression correlated with microbial composition, clinicopathological features, and prognosis of patients with stomach adenocarcinoma

    • Yuting Wen
    • Yi Wang
    • Chan Hui

    Research 08 March 2023 Pages: 7139 - 7153

    

31. Overexpression of the orphan nuclear receptor NR2F6 is associated with improved survival across molecular subgroups in endometrial cancer patients

    • L. Proppe
    • T. Jagomast
    • L. C. Hanker

    Research Open access 08 March 2023 Pages: 7155 - 7164

    

32. Standard deviation of CT radiomic features among malignancies in each individual: prognostic ability in lung cancer patients

    • Si Hongwei
    • Hao Xinzhong
    • Li Sijin

    Research 08 March 2023 Pages: 7165 - 7173

    

33. A clinically applicable prediction model for the risk of in-hospital mortality in solid cancer patients admitted to intensive care units with sepsis

    • ChengYong Ma
    • GuoRui Sun
    • Shuo Yang

    Research 08 March 2023 Pages: 7175 - 7185

    

34. Differential diagnosis of lymphoma with ¹⁸F-FDG PET/CT in patients with fever of unknown origin accompanied by lymphadenopathy

    • Jia Chen
    • Dong Xu
    • Jian-Xin Song

    Research Open access 08 March 2023 Pages: 7187 - 7196

    

35. Diagnosis and treatment of MPN in real life: exploratory and retrospective chart review including 960 MPN patients diagnosed with ET or MF in Germany

    • Andreas Schmidt
    • Christiane Bernhardt
    • Florian H. Heidel

    Research Open access 08 March 2023 Pages: 7197 - 7206

    

36. Virtual screening reveals aprepitant to be a potent inhibitor of neutral sphingomyelinase 2: implications in blockade of exosome release in cancer therapy

    • Milad Moloudizargari
    • Shirin Hekmatirad
    • Mohammad Hossein Asghari

    Research 08 March 2023 Pages: 7207 - 7216

    

37. Repurposing of triamterene as a histone deacetylase inhibitor to overcome cisplatin resistance in lung cancer treatment

    • Kenneth K. W. To
    • Ka M. Cheung
    • William C. S. Cho

    Research 11 March 2023 Pages: 7217 - 7234

    

38. TIMP-2 as a predictive biomarker in 5-Fu-resistant colorectal cancer

    • Yaoqing Li
    • Chuchu Xu
    • Guolin Zhang

    Research 11 March 2023 Pages: 7235 - 7246

    

39. Neuroendocrine differentiation predicts the therapeutic efficacy of abiraterone and docetaxel as first-line therapy in metastatic castration-resistant prostate cancer

    • Nanwei Xu
    • Jinge Zhao
    • Hao Zeng

    Research 13 March 2023 Pages: 7247 - 7258

    

40. The evaluation of tumor microenvironment infiltration and the identification of angiogenesis-related subgroups in skin cutaneous melanoma

    • Junpeng Li
    • Hangjun Ren
    • Xiaolu Li

    Research 13 March 2023 Pages: 7259 - 7273

    

41. Low diffusion capacity predicts poor prognosis in extensive stage small cell lung cancer: a single-center analysis of 10 years

    • Jee Seon Kim
    • Eun Ji Kim
    • June Hong Ahn

    Research Open access 13 March 2023 Pages: 7275 - 7283

    

42. New insights into breast microcalcification for poor prognosis: NACT cohort and bone metastasis evaluation cohort

    • Yangling Hu
    • Lijuan Mao
    • Xiaoling Zhang

    Research 14 March 2023 Pages: 7285 - 7297

    

43. Female breast cancer subtypes in the Romagna Unit of the Emilia-Romagna cancer registry, and estimated incident cases by subtypes and age in Italy in 2020

    • Emanuele Crocetti
    • Alessandra Ravaioli
    • Fabio Falcini

    Research Open access 15 March 2023 Pages: 7299 - 7304

44. Long non-coding RNA ENST00000503625 is a potential prognostic biomarker and metastasis suppressor gene in prostate cancer

    • Yaoming Li
    • Ziyu Fang
    • Luofu Wang

    Research 15 March 2023 Pages: 7305 - 7317

    

45. Intercontinental comparison of women with breast cancer treated by oncologists in Europe, Asia, and Latin America: a retrospective study of 99,571 patients

    • Arturas Kadys
    • Niklas Gremke
    • Matthias Kalder

    Research Open access 15 March 2023 Pages: 7319 - 7326

    

46. FTO-mediated m⁶A modification promotes malignant transformation of gastric mucosal epithelial cells in chronic Cag A⁺ Helicobacter pylori infection

    • Sha Cheng
    • Huan Li
    • Canxia Xu

    Research Open access 15 March 2023 Pages: 7327 - 7340

    

47. Pretherapy investigations using highly robust visualized biomarkers from CT imaging by multiple machine-learning techniques toward its prognosis prediction for ALK-inhibitor therapy in NSCLC: a feasibility study

    • Jingjing Sun
    • Feng Li
    • Lei Shi

    Research 16 March 2023 Pages: 7341 - 7353

    

48. The effect of gastrointestinal microbiome supplementation on immune checkpoint inhibitor immunotherapy: a systematic review

    • Anjali Bhatt
    • Alyson Haslam
    • Vinay Prasad

    Research Open access 16 March 2023 Pages: 7355 - 7362

    

49. Antitumor effect of neoantigen-reactive T cells combined with PD1 inhibitor therapy in mouse lung cancer

    • Huan Qin
    • Haiyan Hu
    • Qiang Li

    Research 18 March 2023 Pages: 7363 - 7378

    

50. Machine learning-based immune prognostic model and ceRNA network construction for lung adenocarcinoma

    • Xiaoqian He
    • Ying Su
    • Wenjia Guo

    Research 20 March 2023 Pages: 7379 - 7392